DalsnaFinance

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Markets Reuters By Reuters 29 Jun 2026 08:15 1 min read
French biotech company Ipsen to buy Kartos Therapeutics for $450 million

French biotech company Ipsen to buy Kartos Therapeutics for $450 million  Reuters

French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters

Read the full story on Reuters → Opens the original article on news.google.com

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.